What is the share price of Kimia Biosciences Ltd (KIMIABL) today?
The share price of KIMIABL as on 11th July 2025 is ₹68.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Kimia Biosciences Ltd (KIMIABL) share?
The past returns of Kimia Biosciences Ltd (KIMIABL) share are- Past 1 week: -1.93%
- Past 1 month: 46.15%
- Past 3 months: 66.68%
- Past 6 months: 68.08%
- Past 1 year: 27.98%
- Past 3 years: 92.51%
- Past 5 years: 166.43%
What are the peers or stocks similar to Kimia Biosciences Ltd (KIMIABL)?
The peers or stocks similar to Kimia Biosciences Ltd (KIMIABL) include:What is the market cap of Kimia Biosciences Ltd (KIMIABL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kimia Biosciences Ltd (KIMIABL) is ₹323.34 Cr as of 11th July 2025.What is the 52 week high and low of Kimia Biosciences Ltd (KIMIABL) share?
The 52-week high of Kimia Biosciences Ltd (KIMIABL) is ₹86.85 and the 52-week low is ₹35.10.What is the PE and PB ratio of Kimia Biosciences Ltd (KIMIABL) stock?
The P/E (price-to-earnings) ratio of Kimia Biosciences Ltd (KIMIABL) is 33.65. The P/B (price-to-book) ratio is 979.80.Which sector does Kimia Biosciences Ltd (KIMIABL) belong to?
Kimia Biosciences Ltd (KIMIABL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Kimia Biosciences Ltd (KIMIABL) shares?
You can directly buy Kimia Biosciences Ltd (KIMIABL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Kimia Biosciences Ltd
KIMIABL Share Price
KIMIABL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
KIMIABL Performance & Key Metrics
KIMIABL Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
33.65 | 979.80 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.68 | 6.41 | 0.79% |
KIMIABL Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
KIMIABL Company Profile
The company makes bulk drug intermediates. It manufactures bulk drugs intermediates for Indian pharmaceutical companies on contract manufacturing basis. It also offers finish goods and fine chemicals.
KIMIABL Forecast
KIMIABL Forecasts
KIMIABL
KIMIABL
Income
Balance Sheet
Cash Flow
KIMIABL Income Statement
KIMIABL Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2.05 | 77.32 | 95.25 | 107.25 | 135.17 | 125.83 | 129.73 | 106.52 | 120.24 | 120.24 | ||||||||||
Raw Materials | 0.35 | 60.58 | 72.22 | 79.09 | 103.13 | 96.03 | 106.39 | 67.36 | 98.67 | 98.66 | ||||||||||
Power & Fuel Cost | 0.17 | 1.85 | 2.54 | 3.21 | 4.54 | 6.54 | 7.29 | 5.25 | ||||||||||||
Employee Cost | 0.83 | 7.80 | 8.82 | 10.80 | 14.09 | 15.08 | 16.40 | 15.15 | ||||||||||||
Selling & Administrative Expenses | 0.61 | 2.32 | 2.33 | 3.76 | 4.88 | 6.16 | 7.04 | 6.30 | ||||||||||||
Operating & Other expenses | 0.48 | 1.44 | 2.43 | 4.97 | -2.30 | 0.46 | -2.58 | 11.30 | ||||||||||||
EBITDA | -0.39 | 3.33 | 6.91 | 5.42 | 10.83 | 1.56 | -4.81 | 1.16 | 21.57 | 21.58 | ||||||||||
Depreciation/Amortization | 0.35 | 1.14 | 1.10 | 1.66 | 1.91 | 2.94 | 3.33 | 3.29 | 3.38 | 3.39 | ||||||||||
PBIT | -0.74 | 2.19 | 5.81 | 3.76 | 8.92 | -1.38 | -8.14 | -2.13 | 18.19 | 18.19 | ||||||||||
Interest & Other Items | 0.27 | 0.58 | 2.00 | 2.53 | 3.39 | 3.64 | 4.25 | 5.05 | 4.56 | 4.56 | ||||||||||
PBT | -1.01 | 1.61 | 3.81 | 1.23 | 5.53 | -5.02 | -12.39 | -7.18 | 13.63 | 13.63 | ||||||||||
Taxes & Other Items | -0.08 | -0.06 | -0.05 | -0.16 | 0.43 | -1.32 | -3.04 | -1.88 | 4.02 | 4.02 | ||||||||||
Net Income | -0.93 | 1.67 | 3.86 | 1.39 | 5.10 | -3.70 | -9.35 | -5.30 | 9.61 | 9.61 | ||||||||||
EPS | -1.26 | 1.52 | 2.64 | 0.46 | 1.09 | -0.78 | -1.98 | -1.12 | 2.03 | 2.03 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
KIMIABL Company Updates
KIMIABL Stock Peers
KIMIABL Past Performance & Peer Comparison
KIMIABL Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Kimia Biosciences Ltd | 33.65 | 979.80 | — |
Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
Cipla Ltd | 22.75 | 3.83 | 1.08% |
Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
KIMIABL Stock Price Comparison
Compare KIMIABL with any stock or ETFKIMIABL Holdings
KIMIABL Shareholdings
KIMIABL Promoter Holdings Trend
KIMIABL Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
KIMIABL Institutional Holdings Trend
KIMIABL Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
KIMIABL Shareholding Pattern
KIMIABL Shareholding Pattern
KIMIABL Shareholding History
KIMIABL Shareholding History
smallcases containing KIMIABL stock
smallcases containing KIMIABL stock
Looks like this stock is not in any smallcase yet.
KIMIABL Events
KIMIABL Events
KIMIABL Dividend Trend
KIMIABL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
KIMIABL Dividend Trend
KIMIABL has not given any dividends in last 5 years
KIMIABL Dividends
KIMIABL Dividends
KIMIABL Stock News & Opinions
KIMIABL Stock News & Opinions
Kimia Biosciences announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 22 July 2025.Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 25 June 2025.Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 26 May 2025.Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 5 May 2025.Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 23 April 2025.Powered by Capital Market - Live
Net profit of Kimia Biosciences reported to Rs 4.57 crore in the quarter ended December 2024 as against net loss of Rs 1.95 crore during the previous quarter ended December 2023. Sales rose 15.15% to Rs 30.10 crore in the quarter ended December 2024 as against Rs 26.14 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales30.1026.14 15 OPM %16.61-4.02 - PBDT4.41-1.78 LP PBT3.59-2.60 LP NP4.57-1.95 LP Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
Kimia Biosciences announced that the Annual General Meeting(AGM) of the company will be held on 28 December 2024.Powered by Capital Market - Live
Kimia Biosciences will hold a meeting of the Board of Directors of the Company on 5 December 2024Powered by Capital Market - Live
Net profit of Kimia Biosciences reported to Rs 1.61 crore in the quarter ended September 2024 as against net loss of Rs 2.44 crore during the previous quarter ended September 2023. Sales rose 16.45% to Rs 28.18 crore in the quarter ended September 2024 as against Rs 24.20 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales28.1824.20 16 OPM %11.96-8.10 - PBDT2.70-2.44 LP PBT1.91-3.26 LP NP1.61-2.44 LP Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 2.31%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.04% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 47.21%, vs industry avg of 20.04%